Sponsors & Exhibitors

Avanti Polar Lipids, Inc. Since 1967 we have served the lipid community with the highest purity manufacturing, specialty products and lipid analysis.Avanti’s eight Divisions are concentrated in one central USA location:Research Products-Highest...

Benchmark Research sites are the industry leader in vaccine clinical research. Our experience includes high-volume patient recruitment and retention for healthy or indication-specific vaccine studies across all demographics and age groups, while...

Mabtech is a Swedish Biotech company that develops and markets high quality monoclonal antibodies and kits for ELISA, ELISpot and FluoroSpot since 1986. We continuously strive to optimize the ELISpot/FluoroSpot method, which has made us a world...

MedGenome, Inc., headquartered in Silicon Valley, is a leading provider of genomic solutions with a mission to improve global health by developing deep insights into diseases at the genetic and molecular level. MedGenome’s genomic technologies and...

With more than 75 members the Sealy Center for Vaccine Development (SCVD) incorporates the expertise of more than 100 cutting-edge research programs. The faculty and staff of the SCVD strive to create, perfect, and promote the most effective and...

Ichor is dedicated to the clinical application and commercialization of its TriGrid® electroporation technology for the delivery of nucleic acid based biologics to treat a broad spectrum of disease indications including cancer, chronic viral...

California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA...

Vaxart is a privately held, clinical-stage company developing tablet vaccines. The company’s proprietary delivery platform is suitable to deliver any recombinant vaccine in oral form and allows rapid development to address emerging threats. Vaxart...

VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like...

Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The company is committed to providing highly effective and competitive vaccines and...